BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18372392)

  • 1. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
    Qin B; Anderson RA; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production.
    Pan M; Cederbaum AI; Zhang YL; Ginsberg HN; Williams KJ; Fisher EA
    J Clin Invest; 2004 May; 113(9):1277-87. PubMed ID: 15124019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosyltransferase GLT8D2 positively regulates ApoB100 protein expression in hepatocytes.
    Wei HS; Wei HL; Zhao F; Zhong LP; Zhan YT
    Int J Mol Sci; 2013 Oct; 14(11):21435-46. PubMed ID: 24173238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents.
    Ota T; Gayet C; Ginsberg HN
    J Clin Invest; 2008 Jan; 118(1):316-32. PubMed ID: 18060040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VLDL Biogenesis and Secretion: It Takes a Village.
    van Zwol W; van de Sluis B; Ginsberg HN; Kuivenhoven JA
    Circ Res; 2024 Jan; 134(2):226-244. PubMed ID: 38236950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRP11-675F6.3 responds to rapamycin treatment and reduces triglyceride accumulation via interacting with HK1 in hepatocytes by regulating autophagy and VLDL-related proteins.
    Wang L; Fang X; Yang Z; Li X; Cheng M; Cheng L; Wang G; Li W; Liu L
    Acta Biochim Biophys Sin (Shanghai); 2023 Oct; 55(10):1606-1617. PubMed ID: 37222534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional repletion of children with severe acute malnutrition does not affect VLDL apolipoprotein B-100 synthesis rate.
    Badaloo AV; Forrester T; Reid M; Jahoor F
    J Nutr; 2012 May; 142(5):931-5. PubMed ID: 22437562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.
    Rajesh Y; Sarkar D
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a sweetpotato protein digest on lipid metabolism in mice administered a high-fat diet.
    Ishiguro K; Kurata R; Shimada Y; Sameshima Y; Kume T
    Heliyon; 2016 Dec; 2(12):e00201. PubMed ID: 27995201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice.
    Kanuri G; Landmann M; Priebs J; Spruss A; Löscher M; Ziegenhardt D; Röhl C; Degen C; Bergheim I
    Eur J Nutr; 2016 Apr; 55(3):1153-64. PubMed ID: 26003186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet.
    Kasbi-Chadli F; Ferchaud-Roucher V; Krempf M; Ouguerram K
    Eur J Nutr; 2016 Mar; 55(2):589-599. PubMed ID: 25787885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geraniol, alone and in combination with pioglitazone, ameliorates fructose-induced metabolic syndrome in rats via the modulation of both inflammatory and oxidative stress status.
    Ibrahim SM; El-Denshary ES; Abdallah DM
    PLoS One; 2015; 10(2):e0117516. PubMed ID: 25679220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease: what the clinician needs to know.
    Machado MV; Cortez-Pinto H
    World J Gastroenterol; 2014 Sep; 20(36):12956-80. PubMed ID: 25278691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.
    Jung UJ; Choi MS
    Int J Mol Sci; 2014 Apr; 15(4):6184-223. PubMed ID: 24733068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ mice.
    Assini JM; Mulvihill EE; Sutherland BG; Telford DE; Sawyez CG; Felder SL; Chhoker S; Edwards JY; Gros R; Huff MW
    J Lipid Res; 2013 Mar; 54(3):711-724. PubMed ID: 23269394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between mesenteric fat thickness and serum apolipoproteins in patients with peripheral arterial occlusive disease.
    Perelas A; Safarika V; Vlachos IS; Tzanetakou I; Korou LM; Konstantopoulos P; Doulamis I; Ioannidis I; Kornezos I; Gargas D; Klonaris C; Perrea DN; Chatziioannou A
    Lipids Health Dis; 2012 Oct; 11():125. PubMed ID: 23025515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chylomicron: relationship to atherosclerosis.
    Tomkin GH; Owens D
    Int J Vasc Med; 2012; 2012():784536. PubMed ID: 22007304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-fat diet-induced obesity and insulin resistance were ameliorated via enhanced fecal bile acid excretion in tumor necrosis factor-alpha receptor knockout mice.
    Yamato M; Shiba T; Ide T; Seri N; Kudo W; Ando M; Yamada K; Kinugawa S; Tsutsui H
    Mol Cell Biochem; 2012 Jan; 359(1-2):161-7. PubMed ID: 21850461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms for insulin resistance in treated HIV-infection.
    Hruz PW
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):459-68. PubMed ID: 21663839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 mediates hepatic hypersecretion of apolipoprotein B.
    Sparks JD; Cianci J; Jokinen J; Chen LS; Sparks CE
    Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G980-9. PubMed ID: 20651008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.